Veteran Overmedication Prevention Act of 2017

Bill: 115-s-992
Sponsor: Sen. McCain, John [R-AZ]
Introduced: 2017-05-01 in the Senate
Policy area: Armed Forces and National Security
Subjects: Department of Veterans Affairs
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Family relationships
Government employee pay, benefits, personnel management
Government information and archives
Government studies and investigations
Health facilities and institutions
Health information and medical records
Health personnel
Higher education
Hospital care
Marriage and family status
Medicaid
Medical education
Medical research
Medical tests and diagnostic methods
Mental health
Neurological disorders
Prescription drugs
Veterans' medical care

Summary:
action_date: 2017-05-01
text: 

Veteran Overmedication Prevention Act of 2017

 
This bill requires the Department of Veterans Affairs (VA) to contract with the National Academies of Sciences, Engineering, and Medicine to review the deaths of all covered veterans who died by suicide during the last five years, regardless of whether information relating to such deaths has been reported by the Centers for Disease Control and Prevention. A &quot;covered veteran&quot; is any veteran who received VA hospital care or medical services during the five-year period preceding the veteran's death.
 
The review shall include:
 
 
the total numbers of veterans who died by suicide, violent death, or accidental death;
 
the percentage of such veterans with combat experience or related trauma;
 
 each veteran's age, gender, race, and ethnicity;
 
a list of medications and substances prescribed to such veterans;
 
a summary of medical diagnoses that led to such prescriptions in cases of anxiety and depressive disorders;
 
the number of instances in which such a veteran was concurrently on multiple prescribed medications;
 
the number of such veterans who were not taking any prescribed medication;
 
 the percentage of such veterans treated for anxiety or depressive disorders who received a non-medication first-line treatment compared to the percentage who received medication only; 
 
descriptions of how the VA determines and updates clinical practice guidelines for prescribing medications and of VA efforts to maintain appropriate staffing levels for mental health professionals;
 
an analysis of VA's use of systematically measuring pain scores during clinical encounters and how that relates to the number of veterans concurrently on multiple prescribed medications; 
 
identification of VA medical facilities with markedly high prescription rates and suicide rates for treated veterans;
 
 an analysis of VA programs that collaborate with state Medicaid agencies and the Centers for Medicare and Medicaid Services;
 
 an analysis of VA medical center collaboration with medical examiners' offices or local jurisdictions to determine veteran mortality and cause of death;
 
identification of a best practice model to collect and share veteran death certificate data;
 
a description of how data relating to death certificates of veterans is collected, determined, and reported by the VA;
 
an assessment of any apparent patterns based on the review; and
 
recommendations to improve the safety and well-being of veterans. 
 
 
The VA shall ensure that such data is compiled in a manner that allows it to be analyzed across all data fields for purposes of informing and updating VA clinical practice guidelines. 


Legislative actions:
action_date: 2017-05-01
text: Read twice and referred to the Committee on Veterans' Affairs.
action_date: 2017-05-01
text: Introduced in Senate